UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000038064
Receipt number R000042823
Scientific Title EfficAcy and safety of carboPlatin, etoposide and atezOlizumab for the first-line treatment of patients with extensive-stage smaLL cell lung cancer in the real-wOrld setting.
Date of disclosure of the study information 2019/09/24
Last modified on 2021/11/24 12:28:22

No. Disposal Last modified on Item of update
1 Insert 2019/09/20 12:26:37
2 Update 2019/09/24 11:09:31 Recruitment status
3 Update 2019/09/24 11:13:46 Date of disclosure of the study information
4 Update 2020/09/20 09:03:46 Recruitment status
Last follow-up date
5 Update 2021/09/21 10:44:50 Number of participants that the trial has enrolled
6 Update 2021/11/24 12:28:22 Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes